IGM Biosciences Inc (IGMS)
8.89
-0.88
(-8.96%)
USD |
NASDAQ |
Nov 21, 16:00
8.75
-0.14
(-1.57%)
After-Hours: 20:00
IGM Biosciences Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2022
--
Maximum
Jun 2022
--
Average
--
Median
Jun 2022
Debt to Equity Ratio Benchmarks
| Moderna Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 304.51M |
| Total Liabilities (Quarterly) | 225.56M |
| Shareholders Equity (Quarterly) | 78.95M |
| Current Ratio | 5.223 |